Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Jul;73(3):791-6.
doi: 10.1111/j.1476-5381.1981.tb16817.x.

The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid

The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid

T W Stone. Br J Pharmacol. 1981 Jul.

Abstract

1 Adenosine, adenosine 5'-triphosphate (ATP), morphine, noradrenaline, gamma-aminobutyric acid (GABA) phentolamine and amyl nitrite were used to inhibit electrically-evoked contractions of the isolated superfused vas deferens of the mouse. 2 The inhibitory effects of adenosine ATP, morphine, noradrenaline and GABA, which are thought to be due to presynaptic action, were reduced by perfusion with media containing 4-aminopyridine (4AP) or tetraethylammonium (TEA) ions. The inhibitory effects of phentolamine and amyl nitrite were unaffected by 4AP or TEA. 3 Quinidine, which like 4AP and TEA produced some increase to twitch height, did not reduce responses to the various agonists, indicating that an increased muscle contraction was not itself responsible for the reduced responses. 4 It is concluded that antagonism between 4AP and adenosine is not a specific interaction, as had been suggested, but probably reflects an interaction with Ca2+ requiring processes in the presynaptic terminal.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1972 Dec;46(4):764-6 - PubMed
    1. Can J Physiol Pharmacol. 1974 Dec;52(6):1226-9 - PubMed
    1. Br J Pharmacol. 1975 Mar;53(3):323-31 - PubMed
    1. Biophys J. 1976 Jan;16(1):83-6 - PubMed
    1. Br J Pharmacol. 1976 Aug;57(4):551-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources